Par Pharma CEO: Double-Digit Growth
Par Pharamceuticals CEO Pat LePore says that 10 to 12 launches are planned for 2012.
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
